Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feng Cai

Showing results (861-870 of 908) with videos related to

Pageof 91
Sort By:
Vaccine|April 27, 2022
Evaluation of a recombinant five-antigen Staphylococcus aureus vaccine: The randomized, single-centre phase 1a/1b clinical trialsFeng-Cai Zhu, Hao Zeng, Jing-Xin Li, et al.
Signal Transduction and Targeted Therapy|July 16, 2021
Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trialsFan-Yue Meng, Fan Gao, Si-Yue Jia, et al.
Nature Metabolism|June 14, 2024
Concurrent loss of LKB1 and KEAP1 enhances SHMT-mediated antioxidant defence in KRAS-mutant lung cancerHyun Min Lee, Nefertiti Muhammad, Elizabeth L Lieu, et al.
Lancet (London, England)|July 5, 2015
Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trialMing Zeng, Xu-Hu Mao, Jing-Xin Li, et al.
Plos Genetics|April 10, 2018
Massive lateral transfer of genes encoding plant cell wall-degrading enzymes to the mycoparasitic fungus Trichoderma from its plant-associated hostsIrina S Druzhinina, Komal Chenthamara, Jian Zhang, et al.
Science China. Life Sciences|June 25, 2019
Immunogenicity noninferiority study of 2 doses and 3 doses of an Escherichia coli-produced HPV bivalent vaccine in girls vs. 3 doses in young womenYue-Mei Hu, Meng Guo, Chang-Gui Li, et al.
Biorxiv : the Preprint Server for Biology|May 22, 2023
Electron transport chain inhibition increases cellular dependence on purine transport and salvageZheng Wu, Divya Bezwada, Robert C Harris, et al.
Lancet (London, England)|May 26, 2020
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trialFeng-Cai Zhu, Yu-Hua Li, Xu-Hua Guan, et al.
The New England Journal of Medicine|October 23, 2009
A novel influenza A (H1N1) vaccine in various age groupsFeng-Cai Zhu, Hua Wang, Han-Hua Fang, et al.
Cell|June 1, 2024
De novo and salvage purine synthesis pathways across tissues and tumorsDiem H Tran, Dohun Kim, Rushendhiran Kesavan, et al.
Pageof 91

Showing results (861-870 of 908) with videos related to

Sort By:
Pageof 91
Vaccine|April 27, 2022
Evaluation of a recombinant five-antigen Staphylococcus aureus vaccine: The randomized, single-centre phase 1a/1b clinical trialsFeng-Cai Zhu, Hao Zeng, Jing-Xin Li, et al.
Signal Transduction and Targeted Therapy|July 16, 2021
Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trialsFan-Yue Meng, Fan Gao, Si-Yue Jia, et al.
Nature Metabolism|June 14, 2024
Concurrent loss of LKB1 and KEAP1 enhances SHMT-mediated antioxidant defence in KRAS-mutant lung cancerHyun Min Lee, Nefertiti Muhammad, Elizabeth L Lieu, et al.
Lancet (London, England)|July 5, 2015
Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trialMing Zeng, Xu-Hu Mao, Jing-Xin Li, et al.
Plos Genetics|April 10, 2018
Massive lateral transfer of genes encoding plant cell wall-degrading enzymes to the mycoparasitic fungus Trichoderma from its plant-associated hostsIrina S Druzhinina, Komal Chenthamara, Jian Zhang, et al.
Science China. Life Sciences|June 25, 2019
Immunogenicity noninferiority study of 2 doses and 3 doses of an Escherichia coli-produced HPV bivalent vaccine in girls vs. 3 doses in young womenYue-Mei Hu, Meng Guo, Chang-Gui Li, et al.
Biorxiv : the Preprint Server for Biology|May 22, 2023
Electron transport chain inhibition increases cellular dependence on purine transport and salvageZheng Wu, Divya Bezwada, Robert C Harris, et al.
Lancet (London, England)|May 26, 2020
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trialFeng-Cai Zhu, Yu-Hua Li, Xu-Hua Guan, et al.
The New England Journal of Medicine|October 23, 2009
A novel influenza A (H1N1) vaccine in various age groupsFeng-Cai Zhu, Hua Wang, Han-Hua Fang, et al.
Cell|June 1, 2024
De novo and salvage purine synthesis pathways across tissues and tumorsDiem H Tran, Dohun Kim, Rushendhiran Kesavan, et al.
Pageof 91